2022. A Review of the Genetic Variants Affecting Efficacy and Adverse Effects of Standard of Care Treatment in Patients with Chronic Myelogenous Leukemia. Precision Medicine Communications. 2, 1 (Jun. 2022), 43–58. DOI:https://doi.org/10.55627/pmc.002.01.0045.